Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Human papillomavirus (HPV)
Meningococcal disease
NITAG documentation
2015
Clear all
Type of publications
NITAG documentation
(24)
Reports
(1)
SAGE documentation
(7)
Scientific publications
(2)
Systematic reviews (SYSVAC)
(18)
Topics
Agenda & Minutes
(6)
Background paper
(7)
Recommendation
(11)
Available to download in languages
English (EN)
(18)
French (FR)
(7)
Regions
Africa
(1)
Americas
(12)
Europe
(7)
Western Pacific
(3)
Countries
Diseases
Human papillomavirus (HPV)
(15)
Meningococcal disease
(9)
Diphtheria
(1)
Haemophilus influenzae type B
(3)
Hepatitis A
(4)
Hepatitis B
(3)
Influenza
(14)
Measles
(3)
Pertussis
(4)
Pneumococcal disease
(5)
Poliomyelitis
(1)
Rotavirus
(2)
Typhoid
(1)
Yellow fever
(4)
Vaccine topics
Target population
Publication date
2015
(24)
2023
(6)
2022
(9)
2020
(7)
2019
(21)
2018
(23)
2017
(19)
2016
(26)
2014
(28)
2013
(13)
2012
(1)
2011
(10)
2010
(9)
2009
(6)
2008
(5)
2007
(6)
2006
(5)
2005
(1)
2001
(1)
2000
(1)
1997
(1)
24 results found
2015
∙
Jessica MacNeil
Considerations for Use of Serogroup B Meningococcal (MenB) Vaccines in Persons at Increased Risk
2015
∙
JCVI
Draft Minute of the Meeting on 7 October 2015
2015
∙
Joseph Bocchini Jr
Human Papillomavirus (HPV) Vaccine Session
2015
∙
JCVI
JCVI statement on HPV vaccination of men who have sex with men
2015
∙
Haut Conseil de la santé publique
Notice relating to the immunisation recommendations against invasive meningococcal C infections after 24 years, notably in men who have sex with other men (MSM)
2015
∙
ACIP
October 2015 Meeting Minutes
2015
∙
Harrell Chesson
Overview of cost-effectiveness of 9-valent HPV vaccination
2015
∙
CFV
Prévention des infections graves dans les asplénies anatomiques ou fonctionnelles
2015
∙
Lauri Markowitz
Proposed HPV vaccination recommendations
2015
∙
CFV
Recommandations de vaccination contre les méningo- coques pour les personnes à risque accru d’infection invasive et d’exposition : utilisation d’un vaccin quadri- valent conjugué également lors de rappels
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register